Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2015
Total Assets: $5.61B
Liabilities Breakdown FY2015
Total Liabilities: $1.95B
Asset Breakdown
Total Assets: $5.61B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $809.1M | 14.4% |
| Accounts Receivable | $1.15B | 20.5% |
| Inventory | $238.6M | 4.3% |
| Property, Plant & Equipment | $1.59B | 28.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.81B | 32.4% |
Liabilities Breakdown
Total Liabilities: $1.95B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $141.0M | 7.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.81B | 92.8% |